News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Karolinska Development AB: First Patient Dosed in the Phase I/II Study of Umecrine Mood's Candidate Drug for Premenstrual Dysphoric Disorder


5/23/2013 10:52:45 AM



comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES